What question did this study set out to answer?

To investigate the clinicopathological features of pure red cell aplasia (PRCA) linked to immune checkpoint inhibitors (ICIs).

April 23, 2026Postgraduate Medicine0 citations

Clinicopathological characteristics of pure red cell aplasia induced by immune checkpoint inhibitors in cancer patients

View Full Paper

JXJian Xiao LLLicheng Li YLYuxiang Luo

Key Points

To investigate the clinicopathological features of pure red cell aplasia (PRCA) linked to immune checkpoint inhibitors (ICIs).
Analysis of clinical records from cancer patients receiving ICIs.
Identification of cases of PRCA occurring post-treatment.
Evaluation of intervention strategies based on early diagnosis.
PRCA commonly emerges about 3 months after initiation of ICI treatment.
Early diagnosis leads to improved outcomes for affected patients.
Favorable responses to timely interventions were noted.

Abstract

PRCA induced by ICIs is a rare immune-related adverse event that typically occurs around 3 months after treatment. Early identification and appropriate intervention can lead to favorable outcomes.

Ask AI

Helpful

Bookmark

View Full Paper

Cite This Study

Xiao et al. (2026) studied this question.

synapsesocial.com/papers/69e9b80e85696592c86eb7b7 https://doi.org/10.1080/00325481.2026.2662039

Ask AI

Helpful

Bookmark

View Full Paper

April 23, 2026Postgraduate Medicine0 citations

Clinicopathological characteristics of pure red cell aplasia induced by immune checkpoint inhibitors in cancer patients

View Full Paper

JXJian Xiao LLLicheng Li YLYuxiang Luo

Key Points

To investigate the clinicopathological features of pure red cell aplasia (PRCA) linked to immune checkpoint inhibitors (ICIs).
Analysis of clinical records from cancer patients receiving ICIs.
Identification of cases of PRCA occurring post-treatment.
Evaluation of intervention strategies based on early diagnosis.
PRCA commonly emerges about 3 months after initiation of ICI treatment.
Early diagnosis leads to improved outcomes for affected patients.
Favorable responses to timely interventions were noted.

Abstract

PRCA induced by ICIs is a rare immune-related adverse event that typically occurs around 3 months after treatment. Early identification and appropriate intervention can lead to favorable outcomes.

Ask AI

Helpful

Bookmark

View Full Paper

Cite This Study

Xiao et al. (2026) studied this question.

synapsesocial.com/papers/69e9b80e85696592c86eb7b7 https://doi.org/10.1080/00325481.2026.2662039

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Ask AI

Helpful

Bookmark

View Full Paper